Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ramón García-Sanz María-José Jiménez Maria José Terol Javier Briones Meijide |
| Publication date | May 17, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |